flutiform is the first pressurised metered-dose inhaler to combine the ICS, fluticasone propionate, with the fast-acting inhaled LABA, formoterol. 2 flutiform is licensed for asthma maintenance ...
DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Flutiform" report has been added to ResearchAndMarkets.com's offering. Flutiform ([fluticasone propionate + formoterol fumarate]; ...
U.K.-based SkyePharma's Flutiform, an inhaled combination of fluticasone and formoterol, has been launched in Germany by the company's partner, Mundipharma, as an asthma maintenance therapy.
Napp Pharmaceuticals says the UK is the first country in Europe to launch flutiform k-haler, a breath-actuate inhaler for adolescents and adults living with asthma. Napp Pharmaceuticals says the UK is ...
- First presentation of largest ever real-world flutiform(R) study at European Respiratory Society International Congress involving over 2,500 patients - Proportion of patients with well-controlled ...
LONDON (MarketWatch) -- U.K. drug delivery company SkyePharma PLC Tuesday said it has signed a deal with Kyorin Co. Ltd. (4569.TO) to develop and distribute its key experimental product, asthma ...
flutiform k-haler, a Novel Treatment for Adolescents and Adults With Asthma, Now Available in Europe
flutiform k-haler is now available in Europe as an asthma treatment for adults and adolescents (aged 12 years and older) [1] Research indicates that many patients make errors with their inhalers and ...
It's likely that SkyePharma isn't having a "Happy New Year" just yet. That's because the British drug delivery company now stands to face an additional delay of between 6 and 9 months in the approval ...
Cambridge, UK, 16 April 2024 ā Mundipharma and Vectura will now progress development of the reformulation of flutiform ® (fluticasone propionate/formoterol fumarate) following long-term collaboration, ...
LONDON (Alliance News) - Vectura Group PLC said Monday that it launched its flutiform k-haler, an inhaler to treat asthma, in the UK. The company said it expects further launches across Europe to ...
- flutiform k-haler is now available in Europe as an asthma treatment for adults and adolescents (aged 12 years and older)[1] - Research indicates that many patients make errors with their inhalers ...
The two companies have entered into a collaboration agreement to continue the development work of incorporating an environmentally friendly propellant into the formulation of flutiform (fluticasone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results